select trial semaglutide nejm Long-term kidney outcomes of in obesity and cardiovascular disease in the A trial emulation in Nature

The recent proliferation of GLP-1RAs has had a remarkable impact on the management of obesity, diabetes, and cardiovascular risk in the general population, but the impact of these drugs on patients with RA has, to this point, been poorly studied, they concluded

Mule NK, Singh JN

Resolution accelerates when interventions target the underlying mechanisms

Identity confirmation by mass spectrometry, purity quantification by HPLC, and confirmation of low bacterial endotoxin are not optional steps for material that is going to inform published data

The MHRA has stated that it is currently reviewing any evidence for an association between NAION and other GLP-1 receptor agonists

Frequently Asked Questions Are these treatments available now in San Diego